Patrick Purcell

663 total citations
12 papers, 438 citations indexed

About

Patrick Purcell is a scholar working on Pulmonary and Respiratory Medicine, Toxicology and Epidemiology. According to data from OpenAlex, Patrick Purcell has authored 12 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Toxicology and 3 papers in Epidemiology. Recurrent topics in Patrick Purcell's work include Pharmacovigilance and Adverse Drug Reactions (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and Bone health and treatments (1 paper). Patrick Purcell is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and Bone health and treatments (1 paper). Patrick Purcell collaborates with scholars based in Australia and China. Patrick Purcell's co-authors include Ian W. Boyd, David G. Le Couteur, Allan J. McLean, Alexander A. Fisher, Michael C. Davis, Andrew Forbes, John J. McNeil, Richard A. Smallwood, Paul Desmond and Christopher K. Fairley and has published in prestigious journals such as Movement Disorders, The Medical Journal of Australia and Drug Safety.

In The Last Decade

Patrick Purcell

12 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Purcell Australia 9 210 136 108 52 52 12 438
Valérie Gras France 11 63 0.3× 27 0.2× 32 0.3× 31 0.6× 35 0.7× 29 371
Alain Lemoine France 8 201 1.0× 12 0.1× 519 4.8× 40 0.8× 30 0.6× 21 820
J.A. Lockton United Kingdom 11 108 0.5× 25 0.2× 57 0.5× 32 0.6× 4 0.1× 14 458
Esther Salgueiro Spain 10 46 0.2× 8 0.1× 85 0.8× 70 1.3× 31 0.6× 30 396
Ryogo Umetsu Japan 13 51 0.2× 20 0.1× 77 0.7× 110 2.1× 168 3.2× 21 467
Natsumi Ueda Japan 13 56 0.3× 18 0.1× 80 0.7× 111 2.1× 150 2.9× 24 468
Yamato Kato Japan 13 46 0.2× 18 0.1× 69 0.6× 105 2.0× 136 2.6× 25 423
Gloria Manso Spain 9 39 0.2× 6 0.0× 76 0.7× 36 0.7× 26 0.5× 27 299
Yi‐Sheng Liou Taiwan 13 25 0.1× 27 0.2× 52 0.5× 102 2.0× 13 0.3× 20 459
Tomislav Kizivat Croatia 10 58 0.3× 9 0.1× 71 0.7× 25 0.5× 7 0.1× 27 446

Countries citing papers authored by Patrick Purcell

Since Specialization
Citations

This map shows the geographic impact of Patrick Purcell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Purcell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Purcell more than expected).

Fields of papers citing papers by Patrick Purcell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Purcell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Purcell. The network helps show where Patrick Purcell may publish in the future.

Co-authorship network of co-authors of Patrick Purcell

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Purcell. A scholar is included among the top collaborators of Patrick Purcell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Purcell. Patrick Purcell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
McEwen, John, et al.. (2007). Widespread Hyoscine Hydrobromide Toxicity Due to Contract Manufacturer Malpractice. Drug Safety. 30(5). 375–378. 4 indexed citations
2.
McEwen, John, et al.. (2006). The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. Pharmacoepidemiology and Drug Safety. 16(1). 65–73. 16 indexed citations
3.
Purcell, Patrick & Ian W. Boyd. (2005). Bisphosphonates and osteonecrosis of the jaw. The Medical Journal of Australia. 182(8). 417–418. 161 indexed citations
4.
Hill, Richard L., Duncan J. Topliss, & Patrick Purcell. (2003). Pancytopenia associated with leflunomide and methotrexate. Annals of Pharmacotherapy. 37. 149–149. 1 indexed citations
5.
Purcell, Patrick. (2003). Data Mining in Pharmacovigilance. International Journal of Pharmaceutical Medicine. 17(2). 63–64. 3 indexed citations
6.
Fisher, Alexander A., et al.. (2002). Entacapone‐Induced Hepatotoxicity and Hepatic Dysfunction. Movement Disorders. 17(6). 1362–1365. 31 indexed citations
7.
Fisher, Alexander A., et al.. (2002). Citalopram-Induced Severe Hyponatraemia with Coma and Seizure. PubMed. 21(4). 179–187. 25 indexed citations
8.
Purcell, Patrick, et al.. (2002). Statistical Techniques for Signal Generation. Drug Safety. 25(6). 415–421. 32 indexed citations
9.
Purcell, Patrick, et al.. (2000). Toxicity ofPassiflora incarnataL. Journal of Toxicology Clinical Toxicology. 38(1). 63–66. 37 indexed citations
10.
Crawford, Dorothy H., et al.. (1995). Flucloxacillin associated cholestatic hepatitis. European Journal of Clinical Pharmacology. 49(1-2). 81–5. 45 indexed citations
11.
Fairley, Christopher K., Antony Ugoni, Andrew Forbes, et al.. (1995). Risk factors for the development of amoxycillin‐clavulanic acid associated jaundice. The Medical Journal of Australia. 162(12). 638–640. 20 indexed citations
12.
Fairley, Christopher K., John J. McNeil, Paul Desmond, et al.. (1993). Risk factors for development of flucloxacillin associated jaundice.. BMJ. 306(6872). 233–235. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026